EVALUATION OF RESIDUAL ACTIVITY IN THYROID CANCER PATIENTS UNDERGOING TREATMENT WITH I-131
Main Article Content
Abstract
Objective: To evaluate activity and determine the isolation time of patients with thyroid cancer after the patients take the administered dose of I-131.
Subject and method: Our prospective descriptive research on 215 thyroid cancer patients, were treated the administered dose of I-131 of 50 mCi, 100 mCi and 150 mCi. Measure the activity of the patients at different times; compare the results with the regulations and recommendations to determine the isolation period.
Results: The patients receiving administered dose of 50 mCi and 100 mCi can be discharged from hospital after 24 hours and 48 hours respectively; with the highest administered dose of 150 mCi can be discharged after 72 hours.
Conclusion: Each administered dose has different requirements for elimination and discharge time. After discharge, depending on the residual activity, the patient determines how long to limit contact with others.
Article Details
Keywords
Radiation safety, I-131 isotope, Residual activity, External dose rate, Thyroid cancer
References
2. Nguyễn Thị The, Phan Sỹ An, Phạm Văn Thảo (2006), Đánh giá hoạt độ phóng xạ trên bệnh nhân ung thư tuyến giáp điều trị bằng I-131, Đề tài nghiên cứu khoa học Bệnh viện Bạch Mai.
3. Phạm Văn Kiệm (2002), Ung thư tuyến giáp – dịch tễ học – chẩn đoán – điều trị, Bệnh viện Ung bướu Thành phố Hồ Chí Minh.
4. Thông tư số 13/2018/TT-BKHCN, Sửa đổi, bổ sung một số điều của Thông tư liên tịch số 13/2014/TTLT - BKHCN – BYT, Bộ Khoa học – Công nghệ.
5. Hardy, K.J., Walker,B.R., Lindsay,R.S., Kennedy,R.L., Seen,J.R., Pad Field p.l. (1995), Thyroid cancer management, Clin-Endocrinol-Oxf. 42(6) p. 651–655.
6. Radiation Protection Series Publication No. 14.2 (2008), Safety Guide for Radiation Protection in Nuclear Medicine, Australian Radiation Protection and Nuclear Safety Agency.
7. IAEA-PRSM-6 (1996), Manual on Therapeutic uses of Iodine-131, International Atomic Energy Agency, Rev.1.